![](https://static.scientificamerican.com/sciam/cache/file/046EDA5F-4949-4302-A0653D5711A34D28_agenda.jpg?w=275&h=154&fit=crop)
An IVF Embryo Test Aims to Prevent Miscarriages: Is It Worth It?
The test could help ensure a successful pregnancy but still leaves hopeful parents with some difficult decisions
The test could help ensure a successful pregnancy but still leaves hopeful parents with some difficult decisions
Weight bias compounds health problems, and surgeons need to recognize and stop it
Flying to space takes its toll on the human body, and this has spurred new research on radiation and microgravity, as well as advances in remote medicine and telehealth, all of which have potential benefits for people on Earth...
Two years into the pandemic, the COVID-19 drugs pipeline is primed to pump out novel treatments—and fresh uses for familiar therapies.
Research shows that antifat bias lowers the quality of care for higher-weight patients. Here is one patient’s story
Our X and Y chromosomes represent the biggest genetic difference in our species. Medicine routinely ignores their influence. Why?
Some over-the-counter medications can help symptoms, and there are ways to ease isolation
A new study offers a possible answer to the question “Why me?”
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs
Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms
Instructing our cells to make specific proteins could control influenza, autoimmune diseases, even cancer
Different methods of drug delivery give us more tools to fight disease
Solutions to age-related vision problems now come in a bottle. How well do they work?
Hamsters eating Cocoa Krispies reveal inflammation pathways from the olfactory system to the brain
Endless boosting might not be a practical or sustainable strategy, scientists say
The huge jump in cases means more hospitalizations. And children’s small airways can be more easily blocked by infections
But shortages mean that new antivirals and other drugs may be hard to come by
Impaired blood flow leads to loss of limbs
Hopes are high for a class of drug that could treat neurodegenerative conditions—but a recent clinical trial has brought the field up short
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account